These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37410941)

  • 1. Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study.
    Agosti-Gonzalez R; Falcato L; Grischott T; Senn O; Bruggmann P
    Swiss Med Wkly; 2023 Jun; 153():40085. PubMed ID: 37410941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus elimination in Swiss opioid agonist therapy programmes - the SAMMSU cohort.
    Bregenzer A; Bruggmann P; Castro E; Moriggia A; Rothen M; Thurnheer MC; Vernazza P; Scheidegger C
    Swiss Med Wkly; 2021 Mar; 151():w20460. PubMed ID: 33705563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations.
    Bertisch B; Giudici F; Negro F; Moradpour D; Müllhaupt B; Moriggia A; Estill J; Keiser O;
    PLoS One; 2016; 11(5):e0155464. PubMed ID: 27227332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
    Müllhaupt B; Bruggmann P; Bihl F; Blach S; Lavanchy D; Razavi H; Robbins Scott S; Semela D; Negro F
    PLoS One; 2018; 13(12):e0209374. PubMed ID: 30596701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
    Bregenzer A; Krismer C; Wendel S; Roser P; Fux CA
    Swiss Med Wkly; 2022 Dec; 152():40009. PubMed ID: 36509421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.
    Schorr O; Blach S; Thurnheer C; Ruis C; Dufour JF
    PLoS One; 2022; 17(8):e0272518. PubMed ID: 35960770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988-2015.
    Richard JL; Schaetti C; Basler S; Mäusezahl M
    Swiss Med Wkly; 2018; 148():w14619. PubMed ID: 29698546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019.
    Lee Wilkinson A; Pedrana A; Traeger MW; Asselin J; El-Hayek C; Nguyen L; Polkinghorne V; Doyle JS; Thompson AJ; Howell J; Scott N; Dimech W; Guy R; Hellard M; Stoové M;
    Epidemiol Infect; 2021 Dec; 150():e7. PubMed ID: 35249577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C in a Swiss sample of men who have sex with men: whom to screen for HCV infection?
    Schmidt AJ; Falcato L; Zahno B; Burri A; Regenass S; Müllhaupt B; Bruggmann P
    BMC Public Health; 2014 Jan; 14():3. PubMed ID: 24393532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):357-61. PubMed ID: 23657111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.
    Boettiger DC; Law MG; Dore GJ; Guy R; Callander D; Donovan B; O'Connor CC; Fairley CK; Hellard M; Matthews G
    BMC Infect Dis; 2017 Dec; 17(1):740. PubMed ID: 29191154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions.
    Rusch U; Robbins S; Razavi H; Vernazza P; Blach S; Bruggmann P; Müllhaupt B; Negro F; Semela D
    Swiss Med Wkly; 2019 Jan; 149():w14694. PubMed ID: 30673118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.
    Bruggmann P; Negro F; Bihl F; Blach S; Lavanchy D; Müllhaupt B; Razavi H; Semela D
    Swiss Med Wkly; 2015; 145():w14221. PubMed ID: 26715488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV disease burden and population segments in Switzerland.
    Bihl F; Bruggmann P; Castro Batänjer E; Dufour JF; Lavanchy D; Müllhaupt B; Negro F; Razavi H; Scheidegger C; Semela D; Semmo N; Blach S
    Liver Int; 2022 Feb; 42(2):330-339. PubMed ID: 34839578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
    Lebovics E; Torres R; Porter LK
    Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot.
    Stämpfli D; Imfeld-Isenegger TL; Hersberger KE; Messerli M
    BMC Infect Dis; 2023 Jun; 23(1):384. PubMed ID: 37286975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation of hepatitis C based on a mandatory reporting system.
    Sagmeister M; Renner EL; Mullhaupt B; Wong JB
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):25-34. PubMed ID: 11782572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.